Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Journal of Negative Results in Biomedicine|April 26, 2016
Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overloadTippaporn Bualeong, Sied Kebir, Dorothea Hof, et al.Anticancer Research|February 5, 2020
Preoperative Survival Prediction in Patients With Glioblastoma by Routine Inflammatory Laboratory ParametersDaniela Pierscianek, Yahya Ahmadipour, Anna Michel, et al.Journal of Neuro-Oncology|June 15, 2020
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practiceWenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, et al.Oncology Letters|January 21, 2017
18F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumorSied Kebir, Okka Kimmich, Pitt Niehusmann, et al.Oncology Letters|March 7, 2025
[68Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literatureLaurèl Rauschenbach, Felix M Gerach, Christoph Berliner, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 15, 2018
Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastomaSied Kebir, Laurèl Rauschenbach, Gerrit H Gielen, et al.Oncotarget|December 29, 2016
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade gliomaSied Kebir, Zain Khurshid, Florian C Gaertner, et al.Cancer Medicine|November 29, 2016
Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastomaAndreas Müller, Alina Jurcoane, Sied Kebir, et al.Cancers|October 27, 2020
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype GlioblastomaSied Kebir, Teresa Schmidt, Matthias Weber, et al.Neurology|December 14, 2019
Olfactory function as an independent prognostic factor in glioblastomaSied Kebir, Elke Hattingen, Michael Niessen, et al.Pageof 8